Medicare Drug Price Negotiations

CMS set 2027 Medicare prices for 15 drugs, negotiating steep discounts — including a 71% cut for Novo Nordisk’s GLP‑1 drugs Ozempic, Wegovy and Rybelsus to about $274/month, 38% for Austedo and 85% for Janumet. Negotiations for this second batch concluded at the end of October and reiterate IRA selection criteria, while Novo Nordisk asked for clarity on pricing and coverage and HHS credited President Trump’s directive.